All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 3264; fax: +41 22 791 4857; email: tni.ohw@sredrokoob). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: tni.ohw@snoissimrep).
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Overview
HIV/AIDS affects the health and welfare of children and undermines hard-won gains in child survival in some of the highly-affected countries. The 'Manual on paediatric HIV care and treatment for district hospitals' aims to help improve clinical skills among health workers in resource-limited settings. It is intended for use by doctors, middle-level practitioners such as clinical officers and senior nurses in the management of HIV-exposed and -infected infants and children at district hospital levels.
The manual consists of two parts. The first part deals with the management of HIV-infected children when they present with common illnesses and opportunistic infections: cough or difficult breathing, diarrhoea (acute and persistent), fever and malnutrition, anaemia and other haematological manifestations. The second part of the manual covers HIV specific management including diagnosis of HIV infection in infants and children, routine care of HIV-exposed and -infected children, antiretroviral therapy, nutritional support, pain management as well as disclosure and psychosocial support.
Contents
- Development Process
- Acknowledgements
- Introduction to manual
- Part I. Common childhood illnesses in HIV-exposed and infected children
- 1. Cough or difficulty breathing in HIV-exposed and HIV-infected children
- 1.1 Approach to cough or difficulty breathing for the HIV-infected child
- 1.2 Differential diagnosis table of an HIV-infected or HIV-exposed child with cough or difficulty breathing
- 1.3 Pneumonia in HIV-infected or exposed children
- 1.4 PCP (Pneumocystis jiroveci pneumonia)
- 1.5 Lymphoid Interstitial Pneumonitis (LIP)
- 1.6 Pulmonary Tuberculosis in HIV-infected/exposed children
- 1.7 Bronchiectasis
- 1.8 Cytomegalovirus (CMV) Infection
- References for further reading
- 2. Diarrhoea and other gastrointestinal problems in HIV-infected children
- 3. Fever in the HIV-Infected child
- 4. Malnutrition and anaemia including hematologic manifestations
- 1. Cough or difficulty breathing in HIV-exposed and HIV-infected children
- Part II. Paediatric HIV care and Treatment with ART
- 5. Introduction: Infants, children and HIV-infection
- 6. Diagnosis of HIV infection in infants and children
- 7. Routine care for HIV-exposed and infected infants and children
- 8. Antiretroviral Therapy (ART)
- 8.1 When to start ART for infants and children
- 8.2 When to initiate ART in HIV-infected Infants AND CHILDREN UNDER 24 MONTHS (WHO 2010 recommendation)
- 8.3 When to initiate ART in HIV-infected children 24 months of age and older
- 8.4 ART drugs
- 8.5 Clinical and Laboratory Monitoring
- 8.6 Adherence
- 8.7 ARV drug toxicity
- 8.8 IRIS: Inflammatory immune reconstitution syndrome
- 8.9 Substituting drugs because of toxicity in infants and children
- 8.10 Choice of second-line regimens in the event of treatment failure
- References for further reading
- 9. Nutritional Support
- Key Practices for Infant and Young Child Nutrition
- 9.1 Special Considerations for HIV Infection
- 9.2 Prevention of mother-to-child-transmission (MTCT) of HIV via breast feeding
- 9.3 Increased energy requirements of HIV-infected children
- 9.4 Steps For Assessing Child Feeding And Counseling The Caregiver
- 9.5 Management of a severely malnourished child with HIV infection
- References for further reading
- 10. Pain Management in HIV-infected children
- 11. Disclosure and psychosocial support for children
- Annexes Paediatric ART drug formulations and dosages
The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.
The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.